Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Prurisol

Among patients with the severest form of psoriasis in study, those having a baseline IGA score of 3 (“moderate”), the primary endpoint was met in 46% of patients who received 200 mg per day.

At Week 12: 42.8% subjects (ITT) [and 55.0% subjects (PP)] achieved “clear” (0) or “almost clear” (1) in IGA

https://static1.squarespace.com/static/5715352e20c647639137f992/t/583ddc8303596e5fc7e8bf06/1480449160455/Cellceutix_Corporate_Slide+Deck_DERMATOLOGY_November+2016+Website+Vers.pdf

Good luck and GOD bless,

George